Efficacy and Safety of AJU-C52 in Essential Hypertension Patients
Status:
RECRUITING
Trial end date:
2024-08-31
Target enrollment:
Participant gender:
Summary
A Randomized, Double-blind, Multi-center, Phase III study to evaluate the efficacy and safety of the AJU-C52 compared with the combination of C52R1M in patients with essential Hypertension Patients who have inappropriately controlled on C52R1L treament